Investigating Avidity and Neutralizing Ability of SARS-CoV-2 Patient Samples Using Next Gen BLI
Gator Bio Gator Bio
136 subscribers
768 views
5

 Published On Nov 18, 2020

Gator Bio is happy to host Dr. Y. Ruben Luo, a Clinical Chemistry Fellow at the University of California San Francisco.

Dr. Luo will be discussing his latest research of SARS-CoV-2 patient samples. Briefly, Dr. Luo and his team have researched how COVID19 progresses in terms of the immune response. Dr. Luo has developed a number of assays to monitor antibody generation, avidity, and antibody neutralization ability using next generation BLI.

Dr. Luo received his PhD in analytical chemistry from Stanford University, and his BS in chemistry from Peking University, China.

Chapters:
0:00 Contents
0:27 Thin-film / Biolayer interferometry - theory
6:36 Antibody Concentration Study
8:51 Label-free Antibody Avidity Assay
13:28 Label-free Surrogate Virus Neutralization Test
20:44 Time course of Serology Results
21:43 Discussion
23:32 Q&A

To learn more about Gator BLI, visit https://www.gatorbio.com/
#avidity #antibodydiscovery #antibodyneutralization
https://en.wikipedia.org/wiki/Bio-lay...

show more

Share/Embed